FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171297242> ?p ?o ?g. }

• W3171297242 endingPage "e13049" @default.
• W3171297242 startingPage "e13049" @default.
• W3171297242 abstract "e13049 Background: Breast cancer (BC) is the most prevalent tumor in women and the leading cause of cancer death in women. TNBC has the worst prognosis among BC subtypes and limited treatment options, mainly including chemotherapy. The efficacy of immunotherapy is clear for immunogenic tumors, such as melanoma, kidney cancer, non-lung cancer small cell, among others. BC seems to be less immunogenic. Basal-type TNBC present a prominent infiltration of inflammatory cells, suggesting that an immune pathway plays a role in tumorogenesis. The development of immunotherapy (IO)has reached an important turning point in the history of cancer treatment based on the use of the immune system itself to fight tumor cells. PD-L1 overexpression is the only predictive response biomarker for anti-PD-1 / PD-L1 therapy that is accepted in TNBM. Methods: Retrospectively, 68 cases of TNBC from the Pathological Anatomy Service of the Ntra. Sra. De las Mercedes Maternity Institute, of Tucumán, between 2010 and 2016 were analyzed. VENTANA anti PDL1 sp142 assay platform was used. Tumor-infiltrating immune cells (IC) are scored as the proportion of tumor area that is occupied by PD-L1 staining IC of any intensity. A specimen should be considered to have PD-L1 expression if the specimen exhibits ≥ 1% IC. In addition, carcinomas with a proportion greater than 50% of lymphocytic infiltration and its association with the expression of PD L1 were studied according to the recommendations of the International TILs Working group. Results: The median age of the patients was 56 years (21-80). The predominant histological type was non-specific type ductal carcinoma, reported in 45/68 cases (66%), following the medullar 9 / 68 (13%) lobular in 8/68 (11%), metaplastic 3/68 (4%) and other 4%. The tumor grade (G), half of the cases were G 3 with 34/68 (50%), G 2 with 42%. The largest proportion of pts, 42%, had no lymph node (LN) involvement, 33% had between 1 to 3 positive LN and 25% showed 4 or more LN. Stage II 39/68 patients (58%) in stage III 20/68 (30%), I (9%, 6) and IV (3%, 2). 16% (11/68) of the patients were PD-L1 positive. Tumors with lymphocytic infiltration between 0% and 10% expressed 24% (2/37), no expression was observed in tumors with TIls between 10 and 50% and in cases with lymphocytic infiltration greater than 50% expression of PD L was observed 1 in 9/18 cases (50%) (Fisher's exact test, p < 0.0001). Conclusions: It was demonstrated that there is an association between the stromal lymphocytic infiltrate (TILs) and the expression of PD-L1 in tumor cells, in this population of women from Tucumán, which would help to select patients as candidates for anti PD L1 therapies." @default.
• W3171297242 created "2021-06-22" @default.
• W3171297242 creator A5003798304 @default.
• W3171297242 creator A5011012193 @default.
• W3171297242 creator A5040692751 @default.
• W3171297242 creator A5065448712 @default.
• W3171297242 date "2021-05-20" @default.
• W3171297242 modified "2023-09-26" @default.
• W3171297242 title "Association of pathological clinical characteristics, PD L 1 receptor expression (sp 142), with tumor lymphocytic infiltration cells (TILs) in patients (pts) with triple negative breast cancer (TNBC) in Tucumán, Argentina." @default.
• W3171297242 doi "https://doi.org/10.1200/jco.2021.39.15_suppl.e13049" @default.
• W3171297242 hasPublicationYear "2021" @default.
• W3171297242 type Work @default.
• W3171297242 sameAs 3171297242 @default.
• W3171297242 citedByCount "0" @default.
• W3171297242 crossrefType "journal-article" @default.
• W3171297242 hasAuthorship W3171297242A5003798304 @default.
• W3171297242 hasAuthorship W3171297242A5011012193 @default.
• W3171297242 hasAuthorship W3171297242A5040692751 @default.
• W3171297242 hasAuthorship W3171297242A5065448712 @default.
• W3171297242 hasConcept C121608353 @default.
• W3171297242 hasConcept C126322002 @default.
• W3171297242 hasConcept C143998085 @default.
• W3171297242 hasConcept C203014093 @default.
• W3171297242 hasConcept C204232928 @default.
• W3171297242 hasConcept C2777701055 @default.
• W3171297242 hasConcept C2778326572 @default.
• W3171297242 hasConcept C2780110267 @default.
• W3171297242 hasConcept C502942594 @default.
• W3171297242 hasConcept C530470458 @default.
• W3171297242 hasConcept C71924100 @default.
• W3171297242 hasConcept C8891405 @default.
• W3171297242 hasConceptScore W3171297242C121608353 @default.
• W3171297242 hasConceptScore W3171297242C126322002 @default.
• W3171297242 hasConceptScore W3171297242C143998085 @default.
• W3171297242 hasConceptScore W3171297242C203014093 @default.
• W3171297242 hasConceptScore W3171297242C204232928 @default.
• W3171297242 hasConceptScore W3171297242C2777701055 @default.
• W3171297242 hasConceptScore W3171297242C2778326572 @default.
• W3171297242 hasConceptScore W3171297242C2780110267 @default.
• W3171297242 hasConceptScore W3171297242C502942594 @default.
• W3171297242 hasConceptScore W3171297242C530470458 @default.
• W3171297242 hasConceptScore W3171297242C71924100 @default.
• W3171297242 hasConceptScore W3171297242C8891405 @default.
• W3171297242 hasIssue "15_suppl" @default.
• W3171297242 hasLocation W31712972421 @default.
• W3171297242 hasOpenAccess W3171297242 @default.
• W3171297242 hasPrimaryLocation W31712972421 @default.
• W3171297242 hasRelatedWork W1966181922 @default.
• W3171297242 hasRelatedWork W1999292713 @default.
• W3171297242 hasRelatedWork W2101673433 @default.
• W3171297242 hasRelatedWork W2366029130 @default.
• W3171297242 hasRelatedWork W2554176272 @default.
• W3171297242 hasRelatedWork W3154849375 @default.
• W3171297242 hasRelatedWork W3214960410 @default.
• W3171297242 hasRelatedWork W4225127290 @default.
• W3171297242 hasRelatedWork W4301401003 @default.
• W3171297242 hasRelatedWork W80971072 @default.
• W3171297242 hasVolume "39" @default.
• W3171297242 isParatext "false" @default.
• W3171297242 isRetracted "false" @default.
• W3171297242 magId "3171297242" @default.
• W3171297242 workType "article" @default.